Difluprednate Emulsion
Product Images NDC 0378-7518

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Difluprednate (NDC 0378-7518). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Difluprednate Structural Formula (Image 01)

Chemical structure diagram of the active ingredient Difluprednate, showing its steroid backbone with various chemical groups attached, including fluorine atoms and acetate esters, depicted in a two-dimensional format.*

FDA Label Image

Figure 1: Percent Of Subjects With Anterior Chamber Cells Clearing (cell Count = 0) (Image 02)

A bar chart showing the percent of subjects with anterior chamber cells clearing (cell count = 0) for Difluprednate ophthalmic emulsion compared to placebo on Day 8 and Day 15. It indicates higher clearance percentages for Difluprednate (22% on Day 8 and 41% on Day 15) versus placebo (8% on Day 8 and 12% on Day 15) with statistical significance marked (P<0.05).*

FDA Label Image

Figure 2: Percent Of Subjects Who Were Pain Free (Image 03)

A bar graph showing the percent of subjects who were pain free over time. The graph compares Difluprednate ophthalmic emulsion QID (n=107) to placebo (n=220) across three time points: Day 3, Day 8, and Day 15. Difluprednate consistently shows higher percentages of pain-free subjects, with values near 45%, 58%, and 63% respectively, compared to placebo at 25%, 27%, and 35%. Statistically significant differences (P<0.05) are indicated for all days.*

FDA Label Image

Difluprednate Opthalmic Emulsion 0.05% Carton Label (Image 04)

Packaging label for Difluprednate Ophthalmic Emulsion 0.05%, a sterile topical eye medication. The label shows the NDC 0378-7518-35, a 5 mL bottle size, and Mylan Pharmaceuticals Inc. as the manufacturer. It includes storage instructions and a list of inactive ingredients, emphasizing that it is Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.